Research projects
Start of main content
Study of the neuroprotector capacity of the epithelial cells of the choroid plexi as a potential regenerative therapy for Alzheimer's disease
16th national competition for scientific and technical research
Gene and regenerative therapy
Research Centre or Institution : Instituto de Investigación Hospital 2 de Octubre. Madrid.
Abstract
The search for alternative treatments which at least reduce the neurodegeneration characterising diseases such as Alzheimer's is an area of special scientific interest. The choroid plexi are involved in many of the basic aspects of neuronal functioning, including the secretion of a nutritious cocktail of polypeptides. They also play a role in repair processes following a lesion, such as occurs in ischaemia, or in Huntington's disease.
The aim of this study will be to determine the possible neuroprotective effects of the choroid plexus in Alzheimer's disease, by implanting epithelial cells from the choroid plexus in a murine model of Alzheimer's disease.
To this end the following aims are planned:
- To determine the neuroprotective potential of the choroid plexus following implantation in the brain, in an animal model of amyloidosis.
- To create a primary culture of human choroid plexus epithelial cells.
To date, work has been undertaken on the first objective. To this end, primary cultures of choroid plexus epithelial cells have been taken from C57BL6 strain rats 5 days after birth, according to the protocol described by Carro et al. (2002). After being kept in culture for one week, they are implanted in dual transgenic APP/Ps1 mice, which are transporters of mutations in the genes encoding for the amyloid precursor protein (APP) and preseniline 1 as the model for amyloidosis. For this, under anaesthesia with isoforane, and using stereotaxia, epithelial cells from the choroid plexus cultures are implanted bilaterally at the level of the hippocampus. Control animals are given the (saline) medium in which the cells had been re-suspended. Preliminary feasibility and cell implant survival tests are being conducted, with highly positive results one month after implantation.
- Activities related
- Projects related
- News related
- Publications related
-
12
Sep
2022
Conferencia online Diseño de materia supramolecular para señalar y emular sistemas vivos ONLINE www.fundacionareces.tv/directo, Monday, 12 September 2022, 19:00 hours
-
26
Sep
2022
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
-
9
May
2024
Conference Genes de mosca y genes humanos: una comparación Madrid, Jueves 09 de mayo de 2024, 19:00 horas
- Synthetic nanoparticles as an innovative treatment for sepsis (SPRINT-4-SEPSIS) 2018 Senior Researcher : Antonio Artigas Raventós Research Centre or Institution : Instituto de Investigación e Innovación Parc Taulí (I3PT), Corporación Sanitaria i Universitaria Parc Taulí
- Risk Assesment of Bacterial Sepsis using multiomic and bioinformatics tools: an approach towards the Precision Medicine in Infectious Diseases 2018 Senior Researcher : María Teresa Coque González
- Extracellular vesicles biomarkers for the diagnosis and prognosis of post-surgical septic shock 2018 Senior Researcher : Eduardo Tamayo Gómez Research Centre or Institution : Hospital Clínico Universitario de Valladolid
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
Stem cells and organoids. Unlocking their potential to understand and treat disease
Febrero 2018 Nature PapersEnd of main content